文献速递心律失常

运动负荷试验评估左心交感神经切除术治疗遗传性心律失常的疗效

[Treatment efficiency evaluation of left cardiac sympathetic denervation for patients with inherited arrhythmia by exercise-stress test].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2021-08-24

回顾性纳入2006年9月至2020年5月行左心交感神经切除术的5例遗传性心律失常患者(2例CPVT、1例LQT1、2例LQT2),比较术前与术后1个月平板运动试验。术后房性及室性心律失常减少,LQTS患者QTc间期缩短,ΔHRR1降低,基础心率无显著变化;随访中4例无心脏事件,1例因情绪应激发生心脏性猝死。

要点

  • LCSD术后房性及室性心律失常均减少,CPVT患者最严重室性心律失常评分下降。
  • LQTS患者术后QTc间期在基线及峰值心率下均显著缩短。
  • LCSD不影响基础心率,但运动耐量呈下降趋势,ΔHRR1显著降低。

核心结论

  • LCSD手术对交感应激诱发的遗传性心律失常患者具有一定治疗作用且安全性较好。
  • 平板运动试验初步显示LCSD可在不影响心率的前提下控制恶性心律失常并改善猝死预警指标。

研究设计与样本

  • 本研究为回顾性观察性研究,纳入2006年9月至2020年5月在北京清华长庚医院和北京大学人民医院行LCSD的CPVT和LQTS患者。
  • LCSD手术指征为不能耐受β受体阻滞剂或服药后仍存在心律失常事件。
  • 共纳入5例患者,其中2例CPVT、1例LQT1、2例LQT2。
  • 收集术前及术后1个月平板运动试验数据,并随访术后1、3、6、12个月及此后每年。

主要发现

  • 5例患者首发症状均为晕厥,初发症状年龄中位数12(10,16)岁,行LCSD年龄中位数21(16,26)岁。
  • 基础心率术前(65.6±6.5)次/min与术后(68.0±11.1)次/min相似(P=0.57)。
  • 运动耐量术前(12.1±2.8)MET与术后(10.5±2.4)MET相比呈下降趋势(P=0.07)。
  • 3例LQTS患者基线心率QTc由术前(546.6±72.3)ms降至术后(493.0±61.1)ms(P=0.047),峰值心率QTc由术前(516.3±73.7)ms降至术后(486.7±64.2)ms(P=0.035)。
  • ΔHRR1由术前(51.5±21.1)次/min降至术后(32.0±13.9)次/min(P=0.035)。

关键数值与推荐

  • CPVT患者最严重室性心律失常评分:例1由术前4分降至术后3分,例2由术前5分降至术后3分。
  • LQTS患者QTc间期术后较术前显著缩短:基线心率P=0.047,峰值心率P=0.035。
  • 猝死风险指标ΔHRR1术后较术前显著降低(P=0.035)。
  • 随访期间4/5例(80%)无心脏事件生存。

临床怎么用

  • 对不能耐受β受体阻滞剂或服药后仍有心律失常事件的遗传性心律失常患者,可考虑LCSD手术。
  • 术后可通过平板运动试验评估心律失常控制情况及QTc间期、ΔHRR1等猝死预警指标变化。
  • LCSD术后仍需规律口服β受体阻滞剂并定期随访心脏事件及药物调整。

局限性

  • 本研究为回顾性观察性研究,样本量仅5例,结论需更大样本验证。
  • 随访时间中位数仅1年,长期疗效与安全性尚不明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the efficiency of left cardiac sympathetic denervation (LCSD) in inherited arrhythmia patients with adrenergic activity-induced malignant ventricular arrhythmia, and observe exercise-stress test features before and after LCSD. Methods: This retrospective observational study included catecholaminergic polymorphic ventricular tachycardia(CPVT) and long QT syndromes(LQTS) patients who underwent video-assisted LCSD at Beijing Tsinghua Changgung Hospital and Peking University People's Hospital from September 2006 to May 2020. The indications for LCSD surgery were intolerant or refractory to beta-blocker medication. Clinical and exercise-stress tests data of included patients were collected before and 1 month after LCSD. Heart rate, exercise tolerance, atrial and ventricular arrhythmia, QTc interval and predictors for sudden cardiac death were analyzed. Patents were regularly followed up at 1, 3, 6, and 12 months after LCSD and then once every year thereafter. Cardiac events and medication adjustment records were collected. Results: Five patients (2 CPVT, 1 LQT1, and 2 LQT2)were included in the study. All patients experienced syncope as first symptom at the median age of 12(10, 16)years, and underwent LCSD at the median age of 21(16, 26)years, Baseline heart rate was similar before and after LCSD ((65.6±6.5) beats/min vs. (68.0±11.1) beats/min, P=0.57); while maximum workload tended to be lower after LCSD ((12.1±2.8) metabolic equivalents (METS) before surgery vs. (10.5±2.4) METS after surgery, P=0.07). Incidence of atrial and ventricular arrhythmia were significantly reduced post LCSD, and the ventricular arrhythmia score was decreased after LCSD in CPVT patients (4 points before LCSD vs. 3 points after LCSD in case 1;5 points before LCSD vs. 3 points after LCSD in case 2). QTc interval was shortened significantly in three LQTs patients (QTc interval at baseline heart rate: (546.6±72.3) ms before surgery vs. (493±61.1) ms after LCSD, P=0.047; QTc interval at maximal exercise heart rate: (516.3±73.7) ms before surgery vs. (486.7±64.2)ms after LCSD, P=0.035). Additionally, sudden cardiac death risk indicator ΔHRR1 (heart rate decreasing value within the first 1 min during recovery phase) decreased from (51.5±21.1) beats/min before surgery to (32.0±13.9) beats/min after surgery (P=0.035). During a median follow-up of 1(1, 4) year, all five patients were on low dosage of propranolol (37.0±21.7) mg/d. Cardiac events free survival was achieved in four out of 5 patients (80%) after sympathectomy, while 1 case suffered from sudden cardiac death after emotional stress. Conclusion: LCSD surgery can be safely and effectively performed in most hereditary arrhythmia patients with adrenergic activity-induced life-threatening cardiac events. Exercise stress test results show that LCSD could reduce malignant arrhythmias and improve sudden cardiac death risk indicators without decreasing heart rate. 目的: 分析交感应激诱发恶性室性心律失常的遗传性心律失常患者行左颈部交感神经节切除(LCSD)术前及术后的平板运动试验心电图特点,初步评价LCSD的有效性。 方法: 本研究为观察性研究,回顾性地选取2006年9月至2020年5月在北京清华长庚医院和北京大学人民医院心脏中心行LCSD治疗的儿茶酚胺敏感性多形性室性心动过速(CPVT)和长QT综合征(LQTS)患者,LCSD手术指征为不能耐受β受体阻滞剂或服药后存在心律失常事件。收集患者的临床资料,比较LCSD术前及术后1个月平板运动试验心电图,分析心率及运动耐量、房性及室性心律失常、QTc间期、猝死风险评价指标。收集LCSD术后1、3、6、12个月及此后每年的随访数据,随访内容包括有无心脏事件发生及药物调整。 结果: 共纳入5例遗传性心律失常患者,其中2例为CPVT、1例为LQT1、2例为LQT2。5例患者首发症状均为晕厥,初发症状年龄为12(10,16)岁,行LCSD年龄为21(16,26)岁。5例患者LCSD术后平板运动试验过程中基础心率无明显变化[术前(65.6±6.5)次/min比术后(68.0±11.1)次/min,P=0.57];运动耐量呈下降趋势[术前(12.1±2.8)MET比术后(10.5±2.4)MET,P=0.07]。房性心律失常、室性心律失常的发生均较前减少,最严重室性心律失常评分下降(例序1由术前4分降至术后3分,例序2由术前5分降至3分),3例LQTS患者QTc间期下降[术前基线心率QTc(546.6±72.3)ms比术后(493.0±61.1)ms,P=0.047,术前峰值心率QTc(516.3±73.7)ms比术后(486.7±64.2)ms,P=0.035]。猝死相关指标改善,T波电交替(TWA)呈下降趋势,且恢复阶段1 min内心率变化值(ΔHRR1)由术前(51.5±21.1)次/min降至术后(32.0±13.9)次/min(P=0.035)。随访1(1,4)年,5例患者均规律口服普萘洛尔,剂量调整至(37.0±21.7)mg/d,4例患者无心脏事件,仅1例因情绪激动发生心跳骤停导致心脏性猝死。 结论: LCSD手术对交感应激引起遗传性心律失常的患者存在一定的治疗作用,且安全性较好。平板运动试验分析初步示LCSD可在不影响心率的前提下,控制恶性心律失常,改善猝死预警指标。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yang J, Li K, Chen DH, et al. [Treatment efficiency evaluation of left cardiac sympathetic denervation for patients with inherited arrhythmia by exercise-stress test]. Zhonghua Xin Xue Guan Bing Za Zhi. 2021. PMID: 34404189. doi:10.3760/cma.j.cn112148-20200920-00747

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。